Director Phoebe Watkin buys $63K in GEHC shares amid stock weakness, first open-market purchase after prior sales; 6 insiders buying within 14 days.
Director Phoebe Watkin has made her first open-market purchase in the three-year record, breaking a pattern of stock-based compensation and prior open-market sales. She acquired shares at prices well below the 52-week high, a typical window for insider activity. The purchase coincides with a notable cluster: six insiders bought GE HealthCare shares within a 14-day window, a material concentration of insider buying activity. GE HealthCare remains profitable with growing revenue and trades at a reasonable valuation multiple, providing a fundamental backdrop of operational stability. This filing is worth tracking because it marks a shift in Watkin's behavior and occurs as part of a broader wave of insider buying, though the individual transaction size is modest.